Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.
about
EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in BRCA1-deficient mouse mammary tumorsGenome-wide identification, characterization and phylogenetic analysis of 50 catfish ATP-binding cassette (ABC) transporter genesAssociation Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug ReactionABC- and SLC-Transporters in Murine and Bovine Mammary Epithelium--Effects of ProchlorazMembrane transporters in drug developmentIdentification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.Genome-wide associations of signaling pathways in glioblastoma multiformeRole of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.Physiologic and anatomic characterization of the brain surface glia barrier of DrosophilaMulti-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.Toxicological significance of renal Bcrp: Another potential transporter in the elimination of mercuric ions from proximal tubular cellsDiscovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping.Stereoselective interaction of pantoprazole with ABCG2. II. In vitro flux analysis.Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout micePharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP.A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier.Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrierIn vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier.Interaction of oligomeric breast cancer resistant protein (BCRP) with adjudin: a male contraceptive with anti-cancer activity.Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system JuniorChalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoateThe ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous systemOverlapping substrate and inhibitor specificity of human and murine ABCG2.P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazoleABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.Quantitative Analysis of the Human Milk Whey Proteome Reveals Developing Milk and Mammary-Gland Functions across the First Year of Lactation.Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.The ABCG family of membrane-associated transporters: you don't have to be big to be mightyABCG2 transporter: therapeutic and physiologic implications in veterinary species.Canalicular ABC transporters and liver disease.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Species differences in drug transporters and implications for translating preclinical findings to humans.Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications.Liposomes for brain delivery.
P2860
Q27318449-E3D6BF5E-A3F0-41D7-A861-31809437D796Q28488138-4CCDAF30-896D-490E-9C23-E4E6F11D31ADQ28550377-9EE66442-7924-4305-BDDD-77E9EE8DFC00Q28551062-40F5F363-BC2C-4723-A5F5-6E89ABAC5F16Q29616802-8F7C28C6-BA7F-4781-8420-9B828B405EAFQ33506860-45C59833-7D74-4574-8C90-731CC922BB86Q33714593-B453BE19-CF92-4CDC-B1EB-9A62AEC1C714Q34496694-FAF406D1-555A-428C-AE95-9B1D5506CF98Q34640446-85969D71-CD1B-4500-B7A1-31B98A406722Q34871636-7990679D-B309-483D-81D9-F4BE5CAEED67Q35089539-7211AC52-3CA5-41BB-9BCF-A2AFCB695D65Q35585361-E601C955-23B1-4738-9432-A0A9C9A7458EQ35602719-465CE0FC-D9D8-439B-8597-0BBDCA3BA575Q35886142-B5F0A5F5-1C79-48E0-B0D8-3CB9447EF4B7Q35913088-1C18760F-D04F-4964-A054-24B0EAA98868Q35996449-36744BB8-42F6-46D7-838C-7C77481BF8A4Q36110576-8DE724DB-1449-4565-9528-82C906E53515Q36386154-7C2D8718-02F0-4CC4-9A6E-6F1BA19BF32BQ36476735-99A96044-FDDC-49F7-BE39-CD7B167FA58EQ36509809-849B811F-4AD8-4CC8-B546-DA2410758236Q36717154-E0429875-A48B-47B8-BC10-AA755DB08296Q36767061-8E8C7F9D-4461-471B-8D45-6260B0B4B10AQ36843054-F5875A22-F703-4956-80EF-97323B002C6FQ36852514-BFDD66E7-50D4-4C60-931E-70B50CDCEC5FQ36949864-39A65583-2809-4ACC-92BD-98942B6A42F0Q37059699-4B65E27E-29B6-454D-8F7B-0FEAE3FB60C0Q37193073-EE0554B8-2423-4AA8-BFDC-AE8894CC8E65Q37390601-42D755A0-1EE4-48FD-A607-C6394665277BQ37409373-B4D363D3-B19D-4E2B-B55A-6B9AE60CC54AQ37471097-8B38B79B-A37C-4B6F-AC1C-27131B1292C9Q37558398-4759DE8C-558E-4545-AC74-31DFE485E3DBQ37636449-D3BF6998-77AA-4F55-B38A-9CA7C2F6FD28Q37790379-F9159A85-DDE4-4B90-8C6F-45E837E18AF9Q37822832-F1495D4E-CC3F-4A23-A744-A2D83BD96E76Q37885400-E8B993DA-7535-41D1-BAA7-7CEC25223960Q37943784-64E519F2-856D-444F-AD83-4FF5C1251715Q38044958-5964D202-5F4D-4228-9F2B-7B97B25A0930Q38068912-9100BA5D-7A43-435A-BD27-FB9D48FB1181Q38071700-C11E528F-FEA0-4AAD-818E-2781272F7EDCQ38078421-775F37B2-1BCC-40D6-8A5E-DFE0061336C8
P2860
Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Physiological and pharmacologi ...... ndings in Abcg2 knockout mice.
@ast
Physiological and pharmacologi ...... ndings in Abcg2 knockout mice.
@en
Physiological and pharmacological roles of ABCG2
@nl
type
label
Physiological and pharmacologi ...... ndings in Abcg2 knockout mice.
@ast
Physiological and pharmacologi ...... ndings in Abcg2 knockout mice.
@en
Physiological and pharmacological roles of ABCG2
@nl
prefLabel
Physiological and pharmacologi ...... ndings in Abcg2 knockout mice.
@ast
Physiological and pharmacologi ...... ndings in Abcg2 knockout mice.
@en
Physiological and pharmacological roles of ABCG2
@nl
P2093
P1476
Physiological and pharmacologi ...... ndings in Abcg2 knockout mice.
@en
P2093
Alfred H Schinkel
Jurjen S Lagas
Maria L H Vlaming
P356
10.1016/J.ADDR.2008.08.007
P407
P577
2008-12-07T00:00:00Z